1 / 17

Measuring Cost and Impact

Measuring Cost and Impact. Nick Hex Project Director 28 March 2012. Understanding the economics – why is it important?. Importance of cost effectiveness in decision-making; Changing commissioning landscape; Funding restrictions – QIPP; NHS Outcomes Framework. Increasing survivorship.

svein
Télécharger la présentation

Measuring Cost and Impact

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Measuring Cost and Impact Nick Hex Project Director 28 March 2012

  2. Understanding the economics – why is it important? • Importance of cost effectiveness in decision-making; • Changing commissioning landscape; • Funding restrictions – QIPP; • NHS Outcomes Framework.

  3. Increasing survivorship

  4. Economic costing • February – October 2011: • Models of the costs of different approaches to survivorship; • Based on activity and costs at 4 pilot sites; • Proxy costs and assumptions used.

  5. Economic costing • Key findings: • The costs of LTFU care costs in secondary care have been reduced by risk stratification of patients • New models of care increase capacity to provide care for more survivors; • But good practice models of care may require additional costs.

  6. Economic modelling

  7. Objectives • Our remit: • Identify additional variables that will influence the cost of the new pathways and describe the effects of these; • Produce a more detailed model of costs for a LTFU service; • Develop the costing methodology into a model which can be easily used by commissioners and care providers to understand the costs of survivorship.

  8. Additional cost factors • Implementation and start-up costs; • Quality improvements, eg, care coordinators, transition clinics etc; • Services outside the acute sector.

  9. Literature review • Very little data or published studies; • Costs, but no activity, for primary care; • Services outside the acute sector do not have negative impacts on patient care.

  10. Economic modelling: inputs

  11. Economic modelling: inputs • Investigation costs; • Quality additions; • Additional primary care visits: • GP time; • Investigations. • Tariff income.

  12. Costing scenarios • Costs of treating 900 survivors with and without risk stratification; • The effect on the commissioning body and the hospital provider of changing service provision, ie. the impact of changing tariff income

  13. Scenario 1: hospital costs

  14. Scenario 2: tariff impact

  15. In summary • Costing model indicates that hospitals may reduce costs through risk stratification but tariff income may also be reduced; • Commissioners likely to incur additional primary care costs; • More research needed around outcomes and the provision of services outside of secondary care;

  16. Next steps • Finalise model and issue for consultation, along with a user guide; • Develop further scenarios; • Draft report for NHS Improvement/NCSI.

  17. Thank you Nick Hex nick.hex@york.ac.uk 01904 324830

More Related